Federal Register / Vol. 88, No. 201 / Thursday, October 19, 2023 / Notices 72087 

Information Collection Clearance 

Officer, Room 14N136B, 5600 Fishers 

Lane, Rockville, MD 20857. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and draft 

instruments, email paperwork@hrsa.gov 

or call Joella Roland, the HRSA 

Information Collection Clearance Officer 

at (301) 443–3983. 

SUPPLEMENTARY INFORMATION: When 

submitting comments or requesting 

information, please include the 

information request collection title for 

reference. 

Information Collection Request Title: 

Bureau of Health Workforce 

Performance Data Collection, OMB No. 

0915–0061—Revision. 

Abstract: Over 50 Bureau of Health 

Workforce (BHW) programs award 

grants to health professions schools and 

training programs across the United 

States to develop, expand, and enhance 

training, and to strengthen the 

distribution of the health workforce. 

These programs are governed by titles 

III, VII, and VIII of the Public Health 

Service Act. Performance information is 

collected in the HRSA Performance 

Report for Grants and Cooperative 

Agreements. Data collection activities 

consisting of an annual progress report 

and an annual performance report 

satisfy statutory and programmatic 

requirements for performance 

measurement and evaluation (including 

specific title III, VII and VIII 

requirements), as well as Government 

Performance and Results Act of 1993 

(GPRA), the GPRA Modernization Act of 

2010, and the Foundations for EvidenceBased Policymaking Act of 2018 

requirements. The performance 

measures were last revised in 2022 to 

ensure they addressed programmatic 

changes, met evolving program 

management needs, and responded to 

emerging workforce concerns. As these 

changes were successful, BHW will 

continue with its current performance 

management strategy and make 

additional changes that reduce burden, 

simplify reporting, reflect new 

Department of Health and Human 

Services and HRSA priorities, and 

enable longitudinal analysis of program 

performance. Specifically, an Excel 

upload feature was implemented for all 

programs to reduce burden. Questions 

on partnerships were revised and 

standardized across forms to understand 

the type and purposes of partnerships 

associated with grant funding. 

Employment-related questions were 

standardized across programs and forms 

to provide consistent outcomes on 

employment location, type of 

employment, and hiring organization. 

New questions were added for programs 

using apprenticeships. Specifically, 

questions were added to measure 

additional employment outcomes 

including role at the employment site 

and vulnerable populations served and 

to measure program satisfaction and 

types of competencies graduates were 

ready to perform. 

Need and Proposed Use of the 

Information: The purpose of the 

proposed data collection is to continue 

analysis and reporting of grantee 

training activities and education, 

identify details about the practice 

locations where trainees work (or plan 

to work) after program completion, and 

report outcomes of funded initiatives. 

Data collected from these grant 

programs will also provide a description 

of the program activities of 

approximately 1,828 reporting grantees 

to inform policymakers on the barriers, 

opportunities, and outcomes involved 

in health care workforce development. 

The proposed measures focus on four 

key outcomes: 

(1) increasing the workforce supply of 

well-educated practitioners in needed 

professions, 

(2) increasing the number of 

practitioners that practice in 

underserved and rural areas, 

(3) enhancing the quality of 

education, and 

(4) supporting educational 

infrastructure to increase the capacity to 

train more health professionals in high 

demand areas. 

Likely Respondents: Respondents are 

awardees of BHW health professions 

grant programs. 

Burden Statement: Burden in this 

context means the time expended by 

persons to generate, maintain, retain, 

disclose, or provide the information 

requested. This includes the time 

needed to review instructions; to 

develop, acquire, install, and utilize 

technology and systems for the purpose 

of collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information; to train 

personnel and to be able to respond to 

a collection of information; to search 

data sources; to complete and review 

the collection of information; and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

Total Estimated Annualized Burden 

Hours: 

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Total 

responses 

Average 

burden per 

response 

(in hours) 

Total 

burden hours 

Direct Financial Support Program ....................................... 619 1 619 2.7 1,671.3 

Infrastructure Program ......................................................... 219 1 219 4.8 1,051.2 

Multipurpose or Hybrid Program .......................................... 1,044 1 1,044 3.1 3,236.4 

Total .............................................................................. 1,882 ........................ 1,882 ........................ 5,958.9 

HRSA specifically requests comments 

on: (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions; (2) the accuracy of the 

estimated burden; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2023–23031 Filed 10–18–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[Document Identifier: OS–4040–0010] 

Agency Information Collection 

Request. 30-Day Public Comment 

Request 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 


lotter on DSK11XQN23PROD with NOTICES1
72088 Federal Register / Vol. 88, No. 201 / Thursday, October 19, 2023 / Notices 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, is publishing the 

following summary of a proposed 

collection for public comment. 

DATES: Comments on the ICR must be 

received on or before November 20, 

2023. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain . Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: 

Sagal Musa, sagal.musa@hhs.gov or 

(202) 205–2634. When submitting 

comments or requesting information, 

please include the document identifier 

4040–0010–30D and project title for 

reference. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collections: Project/ 

Performance Site Location(s), Project 

Abstract, and Key Contacts forms. 

Type of Collection: Revision. 

OMB No. 4040–0010. 

Abstract: The Project/Performance 

Site Location(s), Project Abstract, and 

Key Contacts forms provide the Federal 

grant-making agencies an alternative to 

the Standard Form 424 data set and 

form. Agencies may use Project/ 

Performance Site Location(s), Project 

Abstract, and Key Contacts forms for 

grant programs not required to collect 

all the data that is required on the SF– 

424 core data set and form. 

Type of respondent: Project/ 

Performance Site Location(s), Project 

Abstract, and Key Contacts forms are 

used by organizations to apply for 

Federal financial assistance in the form 

of grants. This form is submitted to the 

Federal grant-making agencies for 

evaluation and review. Previously, 26 

Federal grant-making entities were 

using this information collection. This 

information collection will now be 

utilized by 51 Federal grant-making 

agencies and additional grant-making 

entities. To improve the transparency of 

reading and enhance user-friendliness 

of the supporting statement A, language 

modifications were implemented within 

sections 3 through 16. For section 14, 

Cost to the Federal Government was 

adjusted to the 2023 base general 

schedule.Grants.gov is requesting a 

revision of this collection to allow for 

data reporting and publication by 

agencies requesting to use the common 

form. The information collection (IC) 

expires on November 30, 2025. 

Grants.gov seeks a three-year clearance 

of these collections. 

ANNUALIZED BURDEN HOUR TABLE

Forms 

(if necessary) 

Respondents 

(if necessary) Number of respondents 

Number of 

responses per 

respondents 

Average 

burden per 

response 

Total burden hours 

Project/performance site 

location(s).

Grant Applicants ............. 127,281 ........................... 1 1 127,281 

Project Abstract ............... Grant Applicants ............. 230 .................................. 1 1 230 

Key Contacts ................... Grant Applicants ............. 4,566 ............................... 1 1 4,566 

Total .......................... ......................................... 132,077 ........................... 1 1 132,077 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2023–23074 Filed 10–18–23; 8:45 am] 

BILLING CODE 4151–AE–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive Patent 

Commercialization License: Human 

Monoclonal Antibodies That Broadly 

Target Coronaviruses 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The National Institute of 

Allergy and Infectious Diseases, an 

institute of the National Institutes of 

Health, Department of Health and 

Human Services, is contemplating the 

grant of an exclusive patent license to 

Leyden Laboratories B.V., located at 

Emmy Noetherweg 2, 2333 BK Leiden, 

the Netherlands to practice the 

inventions embodied in the patent 

applications listed in the 

SUPPLEMENTARY INFORMATION section of 

this notice. 

DATES: Only written comments and/or 

applications for a license which are 

received by the Technology Transfer 

and Intellectual Property Office, 

National Institute of Allergy and 

Infectious Diseases on or before 

November 3, 2023 will be considered. 

ADDRESSES: Requests for copies of the 

patent applications, inquiries, and 

comments relating to the contemplated 

exclusive patent license should be 

directed to: Dawn Taylor-Mulneix, 

Technology Transfer and Patent 

Specialist, Technology Transfer and 

Intellectual Property Office, National 

Institute of Allergy and Infectious 

Diseases, 5601 Fishers Lane, Suite 2G, 

MSC 9804, Rockville, MD 20852–9804, 

phone number 301–767–5189, or 

dawn.taylor-mulneix@nih.gov. 

SUPPLEMENTARY INFORMATION: The 

following represents the intellectual 

property to be licensed under the 

prospective agreement: U.S. provisional 

application (63/308,898), filed on 

February 19, 2022, and the PCT 

application (PCT/US2023/062324), filed 

on February 9, 2023, entitled ‘‘Human 

Monoclonal Antibodies that Broadly 

Target Coronaviruses’’ (HHS Reference 

No. E–047–2022). All rights in these 

inventions have been assigned to the 

Government of the United States of 

America. 

The prospective exclusive patent 

commercialization license territory may 

be worldwide, and the field of use may 

be limited to: Prevention and treatment 

of coronavirus infection, illness, and 

transmission through mucosal delivery 


lotter on DSK11XQN23PROD with NOTICES1